Tag Archives: @cmrherder
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Make the Deals with COVID-19 Vaccine-Makers Public Now
Matthew Herder and Andrea MacGregor question whether the deals just announced by the federal government with two companies developing COVID-19 vaccines serve the public interest because details about these deals are not publicly available.
Impact Ethics 